Origen de la red de primer grado Ji-Hoon Park.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
TeraImmune, Inc.
 TeraImmune, Inc. BiotechnologyHealth Technology TeraImmune, Inc. engages in the development of customized cell therapies for autoimmune diseases using the patient’s own Treg cells. Its pipeline includes Hemophilia A, Multiple Sclerosis, and B cell lymphoma. The company was founded by Yong-Chan Kim and Ji-Hoon Park in 2016 and is headquartered in Gaithersburg, MD.
1
| Subsidiary | Biotechnology | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ji-Hoon Park a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BAUDAX BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Chungnam National University | College/University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 2 |
| Corea del Sur | 2 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Yong-Chan Kim | 3 |
- Bolsa de valores
- Insiders
- Ji-Hoon Park
- Conexiones Empresas
